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The nuclear receptor superfamily (NRs) comprises ligand-dependent transcrip-
tion regulators, many of which function as homodimers or heterodimers with
RXR. We show that addition of an SRC-1 coactivator-derived peptide to mo-
nomeric liganded retinoic acid receptor (RAR) promotes efficient homodimer
formation. X-ray crystallography revealed that homodimers are asymmetrical,
reminiscent of functional RXR-RAR heterodimers with distinct conformations
of ligand in the two subunits. A global switch to the dimeric state with
a 2RAR:1SRC-1 stoichiometry was also seen using a larger 20kDa domain
of SRC-1. Our study reveals an allosteric mechanism whereby coactivator
binding to one RAR partner affects ligand conformation and H12 position of
the second partner, hrough the dimer interface. A similar control on the recruit-
ment of SRC-1 is also observed with ER in the crystal structures of ERa bound
to agonist ligands and coactivator peptide.
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Identification of ligands that interact with nuclear receptors (NRs) is both a ma-
jor biological problem and an important initial step in drug discovery. Several
in vitro and in vivo techniques are commonly used to screen ligand candidates
against nuclear receptors, however none of the current assays allow screening
without modification of either the protein and/or the ligand in a high-
throughput fashion. Differential scanning fluorimetry (DSF) allows unmodi-
fied potential ligands to be screened as 10mL reactions in 96-well format
against partially purified protein, revealing specific interactors. As a proof of
principle, we used a commercially available NR ligand candidate chemical
library to identify interactors to several well characterized human NRs.
Compounds that interact specifically with NR Ligand Binding Domains stabi-
lize the protein and result in an elevation of the thermal denaturation point as
monitored by the environmentally sensitive dye SYPRO orange. We present
results validating DSF as a new tool for identifying NR ligands and screening
candidate compounds and also present results of orphan NRs currently under
investigation.
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Multi-drug-resistant bacterial infection is the primary cause for death in the
world. Developing antimicrobial agents that act or inhibit through mechanisms
different than those of existing antibacterial drugs offer an advantage in that
resistance mutations will not have developed, and thus have a better prospect
to efficiently kill bacteria. Over the past decade, a significant advancement
has occurred in the use of FtsZ as a target for antimicrobial activity.
FtsZ is a highly conserved multimeric cytoskeleton protein in prokaryotes. It
forms a z-ring structure at the middle plane of the bacterial cell, in which
cooperation with other bacterial proteins eventually propagates cytokinesis.
Binding of GTP to the monomeric FtsZ protein promotes dimerization and pro-
tofilament formation. Affecting the GTPase activity of FtsZ will inhibit dimer-
ization/polymerization and subsequent z-ring formation and eventually inhibits
bacterial cell division. Therefore, FtsZ has become a promising target for the
development of antibacterial drugs.
Recent studies have revealed a number of natural and synthetic small mole-
cules, which target FtsZ and cause lethality in bacteria thus making FtsZ an ex-
cellent target for the development of broad-spectrum antimicrobial drugs.
These inhibitors are classified on the basis of the mode of action or by origin
as natural or synthetic inhibitors. Most inhibitors affect GTPase activity, sub-
sequently affecting cell division. Some inhibitors stabilize protofilaments,
which also affects the formation of the z-ring. Whatever mode of action, all
these inhibitors are lethal to bacteria. However, the mechanism of how various
types of inhibitors binds to FtsZ and eventually inhibits cell division is still to
be evaluated. In this study, we will demonstrate, for the first time, how and towhat site each inhibitor binds on FtsZ protein. Understanding of this mecha-
nism is crucial for the future development of antimicrobial drugs with high
efficacy.
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We have performed physicochemical and statistical analysis of a large dataset
of sequences of the V3 loop of the glycoprotein gp120 from HIV-1 strains with
known coreceptor selectivity, derived from patient data. The entry of HIV-1
into host cells is mediated by the interaction of the V3 loop of gp120 and cor-
eceptors CCR5 and CXCR4 on host cell surfaces, with the aid of viral protein
gp41 and cell receptor CD4. The choice of CCR5 for viral entry is associated
with the asymptomatic cell infection, whereas the choice of CXCR4 is associ-
ated with progression to disease. Given the sequence and structural variability
of the V3 loop, we have searched for persistent physicochemical properties that
may be mediators of coreceptor selectivity and binding using the Los Alamos
HIV Databases [1]. Our electrostatic analysis demonstrates that charge is the
dominant factor that mediates coreceptor selectivity, other factors being the
N6XT/SX9 glycosylation motif and the 11/24/25 rule. We have examined
amino acid propensities for each position of the V3 loop sequence and identi-
fied key amino acids and positions that may affect the coreceptor choice. We
have studied the conformational variability of the V3 loop, using molecular dy-
namics simulations, and identified persistent intramolecular interactions that
may be important for maintaining the electrostatic profile of the V3 loop that
facilitates coreceptor binding. We have used a statistical model to estimate
the probability for coreceptor selectivity, as a function of charge and presence
or absence of glycosylation motif and 11/24/25 rule. We present an integrated
predictive scheme of coreceptor selectivity and binding, which may be useful in
estimating disease progression, and perhaps aiding in tailoring the selection of
anti-HIV drugs for individual patients.
[1] http://www.hiv.lanl.gov/content/index.
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One of the two main drug targets in human immunodeficiency virus-1 (HIV-1)
therapy is the reverse transcriptase (RT) enzyme. Non-nucleoside RT inhibitors
(NNRTIs) are a class of highly specific drugs which bind to a pocket approx-
imately 10 A˚ from the polymerase active site, inhibiting the enzyme allosteri-
cally. It is widely believed that NNRTIs function as ‘‘molecular wedges’’,
disrupting the region between thumb and palm subdomains of the p66 subunit
and locking the thumb in a wide open conformation. Crystal structure data sug-
gests that the binding of NNRTIs forces RT into a wide open conformation in
which the separation is between the thumb and fingers subdomains is much
higher that the apo structure. Using multi-copy molecular dynamics simula-
tions (with a cumulative simulation time of approximately 900 ns) we have cap-
tured RT bound to the NNRTI efavirenz in a previously uncharacterised closed
conformation suggesting that the constraint of thumb motion is not as complete
as previously believed. This conformation is similar to that adopted by the apo
enzyme but with a modified inter-subdomain hinge. We compare the correlated
domain motions of the drug bound and apo enzymes. A more detailed under-
standing of the mechanism of NNRTI inhibition and the effect of their binding
upon domain motion could aid the design of more effective inhibitors and help
identify novel allosteric sights.
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Dioxygenases are bacterial nonheme iron enzymes responsible for the aerobic
catabolism of several intermediates produced by the decomposition of aromatic
compounds that are industrially released in the environment and recalcitrant to
